trial · primary record
Iptacopan (LNP023)
Age-Related Macular Degeneration
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 168 |
| Primary completion | 2026-09-30 |
| Primary endpoint | Development of new incomplete retinal pigment epithelium & outer retinal atrophy or late age-related macular degeneration (AMD) in the early/intermediate AMD eye as determined by optical coherence tomography (OCT) & supported by multimodal imaging |
| Registry ID | NCT05230537 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:47.799Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05230537
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.